Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Aratana Therapeutics Inc (NASDAQ:PETX)

2.75
Delayed Data
As of Feb 10
 +0.07 / +2.61%
Today’s Change
2.60
Today|||52-Week Range
20.63
-50.72%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Rhodes Linda
Chief Scientific Officer
Sale3/06/201520,000$20.00$400.0K-86.01%
Heinen Ernst
Chief Development Officer
Sale7/15/201515,000$17.06$255.9K-84.35%
Rhodes Linda
Chief Scientific Officer
Sale4/27/201511,700$14.78$172.9K-81.11%
Vander Vort John W
Director
Sale3/06/20156,137$20.01$122.8K-86.01%
Rhodes Linda
Chief Scientific Officer
Sale4/27/20153,300$15.78$52.1K-81.11%
Tooman Craig A
Chief Financial Officer
Sale11/09/20153,620$7.52$27.2K-63.77%
Tooman Craig A
Chief Financial Officer
Sale10/02/20153,250$8.06$26.2K-69.44%
Tooman Craig A
Chief Financial Officer
Sale2/01/20162,806$3.36$9.4K-17.91%
Rhodes Linda
Chief Scientific Officer
Gift4/24/201517,200$0.00$0.00-82.66%
Heinen Ernst
Chief Development Officer
Gift1/22/201643,000$0.00$0.00-12.42%
Page of 2